MYC and hepatocellular carcinoma: There were 10 (interferon gamma response, interferon alpha response, allograft rejection, bile acid metabolism, IL-6 JAK stat3 signaling, xenobiotic metabolism, inflammatory response, coagulation, complement, and fatty acid metabolism) and four (MYC targets v1, mitotic spindle, G2M checkpoint, and E2F targets) biological processes (pathways) positively and negatively correlated with CD5L expression in HCC in both datasets (Fig. 1E).